Max Health™ has just been advised by Medsafe that, effective 11 July 2013 the combination injection of Glycopyrronium and Neostigmine (from Martindale) has been registered. This now removes any requirements for Section 29 reporting for this product. We know this will please many of you and we thank you for your co-operation with supplying patient and prescriber names up till now.
Distribution of Glycopyrronium 0.5mg/ml and Neostigmine 2.5mg/ml injection and all other Max Health™ products continues to be handled by OneLink . Products can be ordered from OneLink on:
Phone: 0800 70 80 60
Fax: 0800 266 960
E-mail: customerservices@onelink.co.nz
Glycopyrronium and Neostigmine injection details are as follows:
Name: Glycopyrronium 0.5mg/ml and Neostigmine 2.5mg/ml injection, 10 x 1ml Amp OneLink Code: PHZ 004
Pharmacode: TBC
Price: POA
Please feel free to contact us for further information.
